Shankara Paneesha
7.2K posts

Shankara Paneesha
@Paneeshas
Haemato-oncologist @uhbtrust & Honorary Associate Clinical Professor UoB interested in lymphoma, myeloma, CLL & transplantation. Firm believer in patient choice



Intriguing data from Luan et al. Time of CAR-T infusion may influence outcome. • multicentre retrospect, 1052 pts • rel / ref DLBCL • med infn time 11.48am • every hr later assoc with worse outcome • 1y PFS 51% < 12pm, 35% > 12pm #lymsm ashpublications.org/blood/article-…


A massive thank you to everyone who bought tickets to my guitar raffle these past few weeks. Together you've raised over £50,000 for the Heartlands Hospital Charity appeal. What an incredible achievement and only possible thanks to all of you 🖤 - Tony Keep an eye on your inbox for an email to the winner.

Fantastic talk today by Vaishali Dulobdas at #ASH2025 on effect of immune parameters and IgRT on post CD19 CAR T outcomes. #lymsm #uhbtrust #nickduncan31 @Capt__Kirkwood @immunologydoc @lymphomule @CCHBham @Paneeshas @lymphomahub @DrLindsayG

Fixed-Duration versus Continuous Treatment for Chronic Lymphocytic Leukemia | New England Journal of Medicine nejm.org/doi/full/10.10…





Results from a trial led by Dr @low_helen show that #BloodCancer patients treated with Bruton Tyrosine Kinase inhibitors should continue taking the drug while having COVID-19 vaccinations, as pausing therapy doesn't improve antibody response to the vaccine birminghambrc.nihr.ac.uk/news-and-event…





